CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
63.13
-0.69 (-1.08%)
At close: Oct 12, 2026, 4:00 PM EDT
63.13
0.00 (0.00%)
After-hours: Oct 12, 2026, 4:10 PM EDT
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.6 billion as of October 12, 2026. It is the 3,320th most valuable company in the world and the 1,058th biggest in the United States. Its market cap has increased by 69.69% in one year.
Market Cap
5.60B
Enterprise Value
4.58B
1-Year Change
69.69%
Global Rank
Country Rank
#1,058 United States
Category
ChartMarket Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.60B, an increase of 363.94%. That is a compound annual growth rate of 75.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 5.60B | 67.08% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 6.25B |
| Rhythm Pharmaceuticals | 6.23B |
| Ligand Pharmaceuticals | 6.12B |
| Immunovant | 5.93B |
| Mirum Pharmaceuticals | 5.62B |
| Erasca | 5.45B |
| Oruka Therapeutics | 5.30B |
| PTC Therapeutics | 5.28B |